PHARMA WAY INITIATES COLLABORATION WITH SKI TEAM SWEDEN ALPINE

Pharma Way is a new partner of the Swedish Alpine National Team  and  from 1 July 2021 will be a supplier to the Swedish Alpine National Team of the unique product Dot Shot, the world's first Turmeric / Curcumin drink.

"Pharma Way takes inspiration from culturally rooted wisdom and combines it with modern science to deliver interesting concepts to promote health, well-being and performance, something that is reminiscent of how we work within Ski Team Sweden Alpine where we have our foundation in wisdom obtained from our strong Alpine culture and use knowledge and innovation to take the sport towards the future." Says  Tommy Eliasson Winter Alpine manager.

Turmeric is a common spice in Asian cuisine. Curcumin is the bioactive ingredient in turmeric  that gives turmeric its powerful yellow color. Turmeric has long been considered to have healing properties in Eastern medicine and medical use is described in the Ayurvedic litterur several thousand years back in time. Modern scientific literature also shows the potential to promote health as Curcumin has antioxidant properties and is considered to act anti-inflammatory, antiviral and antibacterial and interest in Curcumin is therefore increasing in research.

"Many athletes drink Dot Shot above all for its anti-inflammatory properties. Several of these users have cut back on traditional anti-inflammatory drugs and use Dot Shot which is natural, vegan, and with fewer described side effects than traditional drugs." Says  Mårten Österlund  CEO Pharma Way.

The agreement extends over two seasons in 2021/22 and 2022/23. Both parties look forward to long-term cooperation.

"The basis for the collaboration with the Swedish Alpine national team is based on our common quest for development and the value of combining wisdom and knowledge" We are convinced that our product and cooperation will be able to help the Swedish Alpine national team in their journey towards new successes and medals". Says the company's, CEO Mårten Österlund.


Älterer Post